Research graph
References from A Near-Infrared-II Antibody-Photosensitizer Conjugate for Photoimmunotherapy of Advanced Pancreatic Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Pancreatic cancer
10.1016/s0140-6736(20)30974-0 · 2020 · External reference
Pancreatic cancer: Advances and challenges
10.1016/j.cell.2023.02.014 · 2023 · External reference
The tumour microenvironment in pancreatic cancer-clinical challenges and opportunities
10.1038/s41571-020-0363-5 · 2020 · External reference
Novel Therapies for Pancreatic Cancer
10.1200/op.24.00279 · 2025 · External reference
Therapeutic developments in pancreatic cancer: current and future perspectives
10.1038/s41575-018-0005-x · 2018 · External reference
A guide to cancer immunotherapy: from T cell basic science to clinical practice
10.1038/s41577-020-0306-5 · 2020 · External reference
Pancreatitis points to key role of dendritic cells in pancreatic cancer
10.1038/s41577-023-00885-7 · 2023 · External reference
Top 10 Challenges in Cancer Immunotherapy
10.1016/j.immuni.2019.12.011 · 2020 · External reference
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
10.1155/2019/4508794 · 2019 · External reference
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
10.1038/s41423-024-01226-x · 2024 · External reference
Designing nanotheranostics with machine learning
10.1038/s41565-024-01753-8 · 2024 · External reference
Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation
10.1039/c8cs00001h · 2019 · External reference
Emerging combination strategies with phototherapy in cancer nanomedicine
10.1039/d0cs00215a · 2020 · External reference
Phototherapy in cancer treatment: strategies and challenges
10.1038/s41392-025-02140-y · 2025 · External reference
Photodynamic and photothermal therapies for bacterial infection treatment
10.1002/smo.20220010 · 2023 · External reference
Cancer photo-immunotherapy: from bench to bedside
10.7150/thno.53056 · 2021 · External reference
Recent Progresses in Phototherapy-Synergized Cancer Immunotherapy
10.1002/adfm.201804688 · 2018 · External reference
An NIR-II Absorbing Injectable Hydrogel for Boosted Photo-Immunotherapy Toward Human Papillomavirus Associated Cancer
10.1002/agt2.743 · 2025 · External reference
Near-Infrared Photoimmunotherapy of Cancer
10.1021/acs.accounts.9b00273 · 2019 · External reference
Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
10.1016/j.ccr.2023.215350 · 2023 · External reference
Photon-Driven Dye Induction Pyroptosis: An Emerging Anti-Tumor Immunotherapy Paradigm
10.1002/anie.202417899 · 2025 · External reference
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
10.1002/advs.202002746 · 2021 · External reference
J-Aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy
10.1016/j.nantod.2025.102727 · 2025 · External reference
Photosensitizer-antibody conjugates for detection and therapy of cancer
10.1016/j.addr.2003.09.003 · 2004 · External reference
Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment
10.1038/s41467-024-51253-5 · 2024 · External reference
Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future
10.1021/acs.bioconjchem.9b00055 · 2019 · External reference
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
10.1038/nm.2554 · 2011 · External reference
Aggregation-Induced Emission: Together We Shine, United We Soar
10.1021/acs.chemrev.5b00263 · 2015 · External reference
In vivo, clinical and translational aspects of aggregation-induced emission
10.1038/s44222-025-00342-1 · 2025 · External reference
Recent advances of aggregation-induced emission in body surface organs
10.1002/agt2.470 · 2024 · External reference
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
10.1126/scitranslmed.aad7118 · 2016 · External reference
Molecular Engineering of NIR-II Fluorophores for Improved Biomedical Detection
10.1002/anie.202007040 · 2021 · External reference
The Chemistry of Organic Contrast Agents in the NIR-II Window
10.1002/anie.202114722 · 2022 · External reference
Versatile Types of Inorganic/Organic NIR-IIa/IIb Fluorophores: From Strategic Design toward Molecular Imaging and Theranostics
10.1021/acs.chemrev.1c00553 · 2022 · External reference
A small-molecule dye for NIR-II imaging
10.1038/nmat4476 · 2016 · External reference
A Water-Soluble AIEgen for Noninvasive Diagnosis of Kidney Fibrosis via SWIR Fluorescence and Photoacoustic Imaging
10.1002/adma.202206643 · 2022 · External reference
Multimodal Imaging-Guided Photothermal Immunotherapy Based on a Versatile NIR-II Aggregation-Induced Emission Luminogen
10.1002/anie.202202614 · 2022 · External reference
Immunogenic cell death and DAMPs in cancer therapy
10.1038/nrc3380 · 2012 · External reference
Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report
10.3390/curroncol31030112 · 2024 · External reference
Recent Progresses in Phototherapy-Synergized Cancer Immunotherapy
10.1002/adfm.201804688 · ExternalCitation · doi-reference
A Water-Soluble AIEgen for Noninvasive Diagnosis of Kidney Fibrosis via SWIR Fluorescence and Photoacoustic Imaging
10.1002/adma.202206643 · ExternalCitation · doi-reference
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
10.1002/advs.202002746 · ExternalCitation · doi-reference
Recent advances of aggregation-induced emission in body surface organs
10.1002/agt2.470 · ExternalCitation · doi-reference
An NIR-II Absorbing Injectable Hydrogel for Boosted Photo-Immunotherapy Toward Human Papillomavirus Associated Cancer
10.1002/agt2.743 · ExternalCitation · doi-reference
Molecular Engineering of NIR-II Fluorophores for Improved Biomedical Detection
10.1002/anie.202007040 · ExternalCitation · doi-reference
The Chemistry of Organic Contrast Agents in the NIR-II Window
10.1002/anie.202114722 · ExternalCitation · doi-reference
Multimodal Imaging-Guided Photothermal Immunotherapy Based on a Versatile NIR-II Aggregation-Induced Emission Luminogen
10.1002/anie.202202614 · ExternalCitation · doi-reference
Photon-Driven Dye Induction Pyroptosis: An Emerging Anti-Tumor Immunotherapy Paradigm
10.1002/anie.202417899 · ExternalCitation · doi-reference
Photodynamic and photothermal therapies for bacterial infection treatment
10.1002/smo.20220010 · ExternalCitation · doi-reference
Photosensitizer-antibody conjugates for detection and therapy of cancer
10.1016/j.addr.2003.09.003 · ExternalCitation · doi-reference
Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
10.1016/j.ccr.2023.215350 · ExternalCitation · doi-reference
Pancreatic cancer: Advances and challenges
10.1016/j.cell.2023.02.014 · ExternalCitation · doi-reference
Top 10 Challenges in Cancer Immunotherapy
10.1016/j.immuni.2019.12.011 · ExternalCitation · doi-reference
J-Aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy
10.1016/j.nantod.2025.102727 · ExternalCitation · doi-reference
Pancreatic cancer
10.1016/s0140-6736(20)30974-0 · ExternalCitation · doi-reference
Near-Infrared Photoimmunotherapy of Cancer
10.1021/acs.accounts.9b00273 · ExternalCitation · doi-reference
Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future
10.1021/acs.bioconjchem.9b00055 · ExternalCitation · doi-reference
Versatile Types of Inorganic/Organic NIR-IIa/IIb Fluorophores: From Strategic Design toward Molecular Imaging and Theranostics
10.1021/acs.chemrev.1c00553 · ExternalCitation · doi-reference
Aggregation-Induced Emission: Together We Shine, United We Soar
10.1021/acs.chemrev.5b00263 · ExternalCitation · doi-reference
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
10.1038/nm.2554 · ExternalCitation · doi-reference
A small-molecule dye for NIR-II imaging
10.1038/nmat4476 · ExternalCitation · doi-reference
Immunogenic cell death and DAMPs in cancer therapy
10.1038/nrc3380 · ExternalCitation · doi-reference
Phototherapy in cancer treatment: strategies and challenges
10.1038/s41392-025-02140-y · ExternalCitation · doi-reference
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
10.1038/s41423-024-01226-x · ExternalCitation · doi-reference
Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment
10.1038/s41467-024-51253-5 · ExternalCitation · doi-reference
Designing nanotheranostics with machine learning
10.1038/s41565-024-01753-8 · ExternalCitation · doi-reference
The tumour microenvironment in pancreatic cancer-clinical challenges and opportunities
10.1038/s41571-020-0363-5 · ExternalCitation · doi-reference
Therapeutic developments in pancreatic cancer: current and future perspectives
10.1038/s41575-018-0005-x · ExternalCitation · doi-reference
A guide to cancer immunotherapy: from T cell basic science to clinical practice
10.1038/s41577-020-0306-5 · ExternalCitation · doi-reference
Pancreatitis points to key role of dendritic cells in pancreatic cancer
10.1038/s41577-023-00885-7 · ExternalCitation · doi-reference
In vivo, clinical and translational aspects of aggregation-induced emission
10.1038/s44222-025-00342-1 · ExternalCitation · doi-reference
Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation
10.1039/c8cs00001h · ExternalCitation · doi-reference
Emerging combination strategies with phototherapy in cancer nanomedicine
10.1039/d0cs00215a · ExternalCitation · doi-reference
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
10.1126/scitranslmed.aad7118 · ExternalCitation · doi-reference
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
10.1155/2019/4508794 · ExternalCitation · doi-reference
Novel Therapies for Pancreatic Cancer
10.1200/op.24.00279 · ExternalCitation · doi-reference
Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report
10.3390/curroncol31030112 · ExternalCitation · doi-reference
Cancer photo-immunotherapy: from bench to bedside
10.7150/thno.53056 · ExternalCitation · doi-reference
